Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
about
An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosisPTH [1-34] induced differentiation and mineralization of mandibular condylar cartilageIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormoneIntermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.Editorial: Estrogens and osteoporosisWeekly teriparatide therapy rapidly accelerates bone healing in pyogenic spondylitis with severe osteoporosis.Discoveries, drugs and skeletal disorders.Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone.Bone disease in the elderlyEffect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized ratsEvidence that protease inhibitors reduce the degradation of parathyroid hormone and calcitonin injected subcutaneouslyParathyroid hormone induces differentiation of mesenchymal stromal/stem cells by enhancing bone morphogenetic protein signaling.Parathyroid hormone alters collagen synthesis and procollagen mRNA levels in fetal rat calvaria.In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formationShort-term effects of synthetic human parathyroid hormone-(1--34) administration on bone mineral metabolism in osteoporotic patients.Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women.Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical boneOnce-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates.Additive Effects of Mechanical Marrow Ablation and PTH Treatment on de Novo Bone Formation in Mature Adult Rats.Parathyroid hormone analogues in the treatment of osteoporosis.Recombinant hormones in osteoporosis.Appropriate models for novel osteoporosis drug discovery and future perspectives.Parathyroid Hormone-Related Protein, Its Regulation of Cartilage and Bone Development, and Role in Treating Bone Diseases.Osteoporosis treatment: recent developments and ongoing challenges.Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.Insulin-like growth factor-I and parathyroid hormone: potential new therapeutic agents for the treatment of osteoporosis.Stimulation of creatine kinase activity in rat skeletal tissue in vivo and in vitro by protease-resistant variants of parathyroid hormone fragments.Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.Bone densitometry using computed tomography. Part II: increased trabecular bone density in children with chronic renal failure.Recombinant human parathyroid hormone.Variation in the PTH2R gene is associated with age-related degenerative changes in the lumbar spine.Osteogenesis imperfecta and therapeutics.The role of the liver and kidneys in the pharmacokinetics of subcutaneously administered teriparatide acetate in rats.Continuous infusion of PTH delayed fracture healing in mice
P2860
Q28378676-633E151A-3E6C-4C41-B02B-57223431DE0CQ33789749-FEE3964A-B4CE-401E-AE25-5728E484935AQ33857424-4F2505A3-F04D-46BD-9D09-A7BFA871017AQ33874504-4267785A-52EA-40FF-B791-A160CD2886B6Q34050149-449006F6-7EA3-4A48-B4E4-F093F58869F4Q34112368-0AF8EC56-B228-4C5F-A44F-0E74E5BEEB7BQ34932153-DA952C6F-6C3A-441F-B446-DDF61D066687Q35752203-77AA9FF5-08DC-4200-89D5-3B02377E4A52Q35781009-50BBBF67-2DBE-4717-AA65-95C71F271ECDQ35836995-B67BB21A-8792-47E5-B7A4-E98B544CC85FQ36096178-4F5EEBAB-4DC3-4213-84E0-690F6C338261Q36177028-E5026321-1895-4C5D-9B79-5902A62ED4D4Q36408684-C86E6CE6-0B4F-4C70-8B2D-E29F83A1952AQ36778004-56364864-0858-4B23-AC5B-0642F5CF328DQ37005325-1AF2F114-5BDD-4B2E-997D-D3C7E82C316CQ37017310-52ED8869-3A7C-41CA-AD4E-60523FA497E2Q37051678-4706BA96-F49B-4F34-A927-8DF6CB2BB10CQ37083734-47A7D63C-9BF8-452B-AF4B-13B1AB845383Q37512379-A4CDF0FF-9F4A-410B-B449-C12E495C0867Q37900475-114EDFF8-11A0-4AF0-AF05-956A6C1B4DC0Q38104374-D0C98619-0282-4E7D-B70B-7C52B4162EF2Q38570326-C19DFA23-39A0-4C64-9142-29727323674CQ38824663-32E6096C-9889-4D92-8D64-FFCE6E938D90Q39423904-6B16EB93-C6A5-4015-A8FA-9FF17C463201Q39786262-072EDC02-127B-47FE-A034-6B5744FAB12AQ40409062-B450C7B3-8595-4C7D-87BD-78AA459CE918Q41330405-5E91E6B8-72C6-4A12-B60B-A424E949B0AFQ41473196-E2196689-CCF4-4785-BBD6-8F00D34266FAQ41484003-9053B932-2FAA-4E4F-B7F7-1BEEA33AEE32Q42776161-C2E22784-54EE-42EC-9A78-242C3599AE1EQ43761347-8A53316F-39E9-4EA3-8708-0A9DED1C1240Q52655586-2C4039A6-251B-4788-8EF3-E34DFE5412C7Q54645805-1FADFF80-F5BB-44DE-83C7-344A8FE139B7Q58765386-4C5784BB-DF6B-4C6C-9140-CDBBC1F7CEB4
P2860
Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis.
description
1976 nî lūn-bûn
@nan
1976年の論文
@ja
1976年学术文章
@wuu
1976年学术文章
@zh-cn
1976年学术文章
@zh-hans
1976年学术文章
@zh-my
1976年学术文章
@zh-sg
1976年學術文章
@yue
1976年學術文章
@zh
1976年學術文章
@zh-hant
name
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@en
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@nl
type
label
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@en
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@nl
prefLabel
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@en
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@nl
P2093
P1433
P1476
Anabolic effect of low doses o ...... n postmenopausal osteoporosis.
@en
P2093
D Williams
G W Tregear
J A Parsons
J M Zanelli
L Klenerman
P304
P356
10.1016/S0140-6736(76)92216-9
P407
P577
1976-05-01T00:00:00Z